UHN's Dr. David Jaffray has been awarded $7M in new funds from the Ministry of Research and Innovation's recent Research Excellence Round 4 funding opportunity.

Recent findings from an OCI-led study increase our understanding of the genetics involved in acute myeloid leukemia (AML), a cancer of the blood leading to rapid growth of abnormal white blood cells. These findings may bear important significance in the development of new therapeutic treatments for AML.

Heart failure (HF) is one of the leading reasons for hospitalization; however, for a third of patients with HF visiting the emergency department (ED) who are discharged home, little is known about their outcome in comparison to HF patients admitted to the hospital.